Home
NS Pharma

NS Pharma Market Share Analysis for May 2026

This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger […]

Industry: N/A

Domainnspharma.com

Year Founded1999

Employees51 - 200

Annual Revenue$10M - $15M

NS Pharma

NS Pharma (including company regionals)

nspharma.com

See more website traffic and engagement information

NS Pharma Revenue up to May 2026 is 10M - 15M

revenue generated by NS Pharma top domains

NS Pharma top domains revenue over 3 years

Revenue for NS Pharma top domains

nspharma.com10M - 15M

See more with Sales Intelligence

Total visits to NS Pharma's top domains

Understand NS Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nspharma.com4.3K

See more with Sales Intelligence

Avg. visit duration in NS Pharma's top domains

Analyze NS Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nspharma.com00:01:17

See more with Sales Intelligence

Avg. pageviews on NS Pharma's top domains

See how NS Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nspharma.com1.72

See more with Sales Intelligence

NS Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by NS Pharma

These are the website technologies, by industry, used by NS Pharma top domains

Advertising (6)

PubMatic

Widget (3)

Twemoji

Content Management System (2)

WordPress

Marketing (2)

Google Marketing Platform

More Technologies

8

See all

News & Signals from NS Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCapricor Therapeutics, Inc. files suit against NS Pharma, Inc..Capricor Therapeutics, Inc. (Headquarters: California, USA, CEO: Linda Marbán, NASDAQ: CAPR) announced that it has filed a lawsuit against Nippon Shinyaku and its U.S. subsidiary, NS Pharma, Inc., seeking an injunction against the Commercialization and Distribution Agreement for CAP-1002 (deramiocel) (the Agreement).

NewsNS Pharma, Inc. signs new client U.S. Food and Drug Administration.NS Pharma Inc.'s NS-051 (NCNP-04) has been awarded orphan drug designation by the FDA for the treatment of Duchenne muscular dystrophy (DMD) in patients amenable to exon 51 skipping.

NewsNS Pharma, Inc. is developing therapies for rare diseases.NS Pharma announces strategic alliance with Boston Children's Hospital to develop new therapies for rare diseases.